Altai Announces Shareholder Approval of Special Resolution
Get Alerts ATI Hot Sheet
Join SI Premium – FREE
TORONTO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Altai Resources Inc. (TSXV: ATI) (“Altai” or the “Company”) announced that at today’s special meeting (the “Meeting”) of shareholders of the Company (the “Shareholders”), the Shareholders approved, with approximately 96.4% of the votes cast in favor of, a special resolution (the “Stated Capital Reduction Resolution”) authorizing and approving a reduction of the stated capital account of the common shares of the Company (the “Common Shares”) by an aggregate amount to be determined by the board of directors of the Company from time to time up to a maximum cumulative total amount of $4,000,000 pursuant to Section 34(1)(b) of the Business Corporations Act (Ontario) for the purposes of distributing such amount to holders of Common Shares by way of a return of capital in one or more special cash distribution(s).
ABOUT THE COMPANY
Altai Resources Inc. is a Toronto, Ontario based resource company with an oil property in Alberta and a Canadian investment portfolio comprised of cash and cash equivalents. Additional information about the Company is available on SEDAR+ at www.sedarplus.ca and on the Company’s website at www.altairesources.com.
For further information, please contact:
Kursat Kacira, Chairman & CEO/President
T: (647) 282-8324, E: [email protected]
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.
Source: Altai Resources Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ZenaTech Closes 28th Drone as a Service Acquisition, Adding a Canadian-based Civil and Structural Engineering Firm with Customers Across Five Provinces
- mF International Launches New Corporate and Investor Relations Websites as Strategic Transformation Progresses
- West Cancer Center Receives IRB Approval to Commence IceCure's ChoICE Study for Breast Cancer Cryoablation
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share